CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Embera NeuroTherapeutics, Inc.

For profitWebsite ↗

Also known as: Embera NeuroTherapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 10, 2021

Timeline

2000s

Jun 1, 2005
Embera NeuroTherapeutics, Inc.— Founded

Drugs by trial phase (5 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

emb-01

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT04933916Lead sponsorPhase 1/Phase 2Jun 10, 2021
NCT04933916Study chairPhase 1/Phase 2Jun 10, 2021
NCT04868253CollaboratorPhase 2/Phase 3May 19, 2021
NCT04501874Study chairPhase 2Jul 29, 2020
NCT04501874Lead sponsorPhase 2Jul 29, 2020
NCT03404817Study directorPhase 1Mar 1, 2018
NCT03404817Lead sponsorPhase 1Mar 1, 2018
NCT02856854Lead sponsorPhase 1Jul 1, 2016
NCT02406066Lead sponsorPhase 1Mar 1, 2015
NCT02406066Study directorPhase 1Mar 1, 2015
NCT00567814Lead sponsorN/ADec 1, 2007

Details

Founded: Sudbury, MA, US Jun 1, 2005
Last known activity: Jun 10, 2021